Role of DNAM-1 (CD226) in rapid progressive glomerulonephritis
Role of DNAM-1 (CD226) in rapid progressive glomerulonephritis
批准号:
20890030
负责人:
KAI Hirayasu
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (Start-up)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009
中文摘要
DNAM-1 (CD226)是一种粘附分子,在大多数NK细胞、T细胞、单核细胞和血小板上表达,在物理和功能上与白细胞功能相关抗原-1 (LFA-1)相关。脊髓灰质炎病毒受体(PVR) CD155及其家族成员CD112 (PVR相关家族2 (pr -2),也称为连接素-2)是人和小鼠DNAM-1的配体。我们用抗肾小球基底膜抗体分析了野生型小鼠和DNAM-1 (CD226)基因缺陷小鼠的快速进展性肾小球肾炎。我们将野生型小鼠与dnam1基因缺失小鼠进行比较,发现肾炎程度较弱。提示DNAM-1可能与快速进行性肾小球肾炎的发生有关。
英文摘要
DNAM-1 (CD226) is an adhesion molecule expressed on the majority of NK cells, T cells, monocytes and platelets and physically and functionally associates with leukocyte function-associated antigen-1 (LFA-1). The poliovirus receptor (PVR) CD155 and its family member CD112 (PVR-related family-2 (PRR-2), also called as nectin-2) are ligands for human and mouse DNAM-1. We analyzed rapid progressive glomerulonephritis for wild type mouse and DNAM-1 (CD226) gene deficit mouse using antiglomerulus basement membrane antibody. We compared wild type mouse with the DNAM-1 gene deficit mouse, and the degree of the nephritis was showed weakly. The possibility that DNAM-1 related with the onset of the rapid progressive glomerulonephritis was suggested.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金